Dr. Aleem Gangjee, inaugural Adrian Van Kaam Chair and Mylan School of Pharmacy Distinguished Professor at Duquesne University, was recently invited to give two prestigious presentations.
Gangjee spoke at the third International Symposium on Folate Receptors and Transporters at Zion National Park in Utah on Synthesis, Evaluation and SAR of FR and PCFT Specific Antitumor Agents.
He also addressed a specific agent’s mechanisms of drug resistance before the National Cancer Institute, which is part of the National Institutes of Health. His topic was Synthesis and Discovery of Water Soluble Microtubule Targeting Agents that Bind to the Colchicine Site on Tubulin and Circumvent Pgp Mediated Resistance.
An internationally renowned scholar, Gangjee’s research encompasses areas including anti-cancer drugs, synthetic medicinal chemistry, computer-assisted drug design, and the design and synthesis of multi-acting antitumor agents.
He has been awarded 20 U.S. patents and holds numerous concurrent National Institutes of Health grants, with his total grants exceeding $10 million. Gangjee also has written more than 100 articles that have appeared in publications such as the Journal of Medicinal Chemistry, the Journal of Pharmaceutical Sciences, Bioorganic and Medicinal Chemistry, and the Journal of Organic Chemistry.
Gangjee holds a Ph.D. in medicinal chemistry from the University of Iowa, and a bachelor’s in chemistry and master’s in organic chemistry from the Indian Institute of Technology. He resides in Allison Park.